FDA approves daratumumab in combination with standard therapy for multiple myelomaNovember 22, 2016Lymphoma & Plasma Cell Disorders
NCCN: Deliver vincristine by mini IV drip bagNovember 11, 2016Practice ManagementLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Higher-volume facilities show better myeloma outcomesOctober 26, 2016Lymphoma & Plasma Cell Disorders
Anticipate monoclonals in first-line therapy for multiple myelomaOctober 26, 2016Lymphoma & Plasma Cell Disorders
Hepatitis infection raises non-Hodgkin lymphoma risk in HIV patientsOctober 17, 2016Lymphoma & Plasma Cell Disorders
Expert panel offers treatment recommendations in Waldenström macroglobulinemiaSeptember 27, 2016Lymphoma & Plasma Cell Disorders
ASPIRE trial: carfilzomib boosts quality of life in relapsed MMSeptember 27, 2016Lymphoma & Plasma Cell Disorders
‘Meaningful’ antitumor activity with lenalidomide monotherapy in ATLSeptember 20, 2016Lymphoma & Plasma Cell Disorders
FDA modifies dosage regimen for nivolumabSeptember 19, 2016Lung CancerGenitourinary CancerLymphoma & Plasma Cell DisordersMelanomaRenal Cell Carcinoma
Minimal residual disease negativity predicts better survival in MMSeptember 15, 2016Lymphoma & Plasma Cell Disorders
New anticancer drugs linked to increased costs, life expectancySeptember 12, 2016Genitourinary CancerPractice ManagementLung CancerBreast CancerLymphoma & Plasma Cell Disorders
Pneumonitis with nivolumab treatment shows common radiographic patternsSeptember 6, 2016Lung CancerLymphoma & Plasma Cell DisordersMelanomaPatient & Survivor Care
Is stem-cell transplant curative for HIV infection?August 29, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
